Researchers have developed an injectable inflammation-responsive hydrogel (IRH), which tests in mice showed can deliver an anti-inflammatory drug directly to the retina of the eye. Reporting on in ...

Shares of Kodiak Sciences KOD surged 75% on March 26 after the company announced positive top-line results from the phase III ...

Please provide your email address to receive an email when new articles are posted on . Consensus statements provide useful guidance on current clinical practice patterns and disease pathophysiology ...

Researchers have found in a new study that advanced periodontal inflammation (stage III–IV) may cause degenerative changes in ...

Drug Farm today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DF-003, the company's investigational small molecule inhibitor targeting ALPK1, ...

A new research paper was published in Aging (Aging-US) on January 31, 2025, in Volume 17, Issue 2, titled "Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic ...

A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis. A study published in ...

In July, we reported on cases of unexplained ocular inflammation associated with pegcetacoplan (Syfovre), a treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Many retinal diseases begin long before patients experience noticeable vision loss.Clinicians frequently manage patients with ...